{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:08:27Z","timestamp":1790813307598,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01730-y","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:35:15Z","timestamp":1749602115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CCAT2 role in gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies"],"prefix":"10.1007","volume":"25","author":[{"given":"Ahmad Ghorbani","family":"Vanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Ghorbaninezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Nikeghbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Mohamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariyan","family":"Ayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Ghanbari","family":"Mastani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahhoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooya","family":"Eini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"1","key":"1730_CR1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335-349.e15.","journal-title":"Gastroenterology"},{"issue":"6","key":"1730_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1730_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10654-010-9522-9","volume":"26","author":"M Amiri","year":"2011","unstructured":"Amiri M, Janssen F, Kunst AE. The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol. 2011;26(1):23\u20138.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"1730_CR4","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10): 101174.","journal-title":"Transl Oncol"},{"issue":"10","key":"1730_CR5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1440-1746.2011.06831.x","volume":"26","author":"MS Haerian","year":"2011","unstructured":"Haerian MS, Baum L, Haerian BS. Association of 8q24.21 loci with the risk colorectal cancer: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2011;26(10):1475\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"15","key":"1730_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34375","volume":"10","author":"Y Goudarzi","year":"2024","unstructured":"Goudarzi Y, et al. Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes. Heliyon. 2024;10(15): e34375.","journal-title":"Heliyon"},{"key":"1730_CR7","first-page":"66","volume":"11","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, et al. Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus. Front Cell Dev Biol. 2023;11:66.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1730_CR8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"1730_CR9","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1101\/gad.1800909","volume":"23","author":"JE Wilusz","year":"2009","unstructured":"Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23(13):1494\u2013504.","journal-title":"Genes Dev"},{"issue":"21","key":"1730_CR10","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/emboj.2013.221","volume":"32","author":"G Wan","year":"2013","unstructured":"Wan G, et al. A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. Embo j. 2013;32(21):2833\u201347.","journal-title":"Embo j"},{"issue":"1","key":"1730_CR11","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/s41598-018-21105-6","volume":"8","author":"N Pospiech","year":"2018","unstructured":"Pospiech N, et al. Identification of novel PANDAR protein interaction partners involved in splicing regulation. Sci Rep. 2018;8(1):2798.","journal-title":"Sci Rep"},{"issue":"1","key":"1730_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41467-017-02113-y","volume":"9","author":"Y Miao","year":"2018","unstructured":"Miao Y, et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat Commun. 2018;9(1):292.","journal-title":"Nat Commun"},{"issue":"7","key":"1730_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134120","volume":"10","author":"I Gazy","year":"2015","unstructured":"Gazy I, et al. TODRA, a lncRNA at the RAD51 Locus, is oppositely regulated to RAD51, and enhances RAD51-dependent DSB (Double Strand Break) Repair. PLoS ONE. 2015;10(7): e0134120.","journal-title":"PLoS ONE"},{"issue":"4","key":"1730_CR14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2011.08.054","volume":"147","author":"L Yang","year":"2011","unstructured":"Yang L, et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011;147(4):773\u201388.","journal-title":"Cell"},{"issue":"10","key":"1730_CR15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15476286.2015.1063770","volume":"12","author":"P Han","year":"2015","unstructured":"Han P, Chang CP. Long non-coding RNA and chromatin remodeling. RNA Biol. 2015;12(10):1094\u20138.","journal-title":"RNA Biol"},{"issue":"2","key":"1730_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"Y-T Tan","year":"2021","unstructured":"Tan Y-T, et al. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 2021;41(2):109\u201320.","journal-title":"Cancer Commun"},{"key":"1730_CR17","doi-asserted-by":"crossref","first-page":"767348","DOI":"10.3389\/fgene.2021.767348","volume":"12","author":"DK Soni","year":"2021","unstructured":"Soni DK, Biswas R. Role of non-coding RNAs in post-transcriptional regulation of lung diseases. Front Genet. 2021;12:767348.","journal-title":"Front Genet"},{"issue":"12","key":"1730_CR18","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.3390\/cancers14122952","volume":"14","author":"N Sobhani","year":"2022","unstructured":"Sobhani N, et al. Predictive and prognostic value of non-coding RNA in breast cancer. Cancers (Basel). 2022;14(12):2952.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1730_CR19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s11427-012-4413-9","volume":"55","author":"Z Gong","year":"2012","unstructured":"Gong Z, et al. Long non-coding RNAs in cancer. Sci China Life Sci. 2012;55(12):1120\u20134.","journal-title":"Sci China Life Sci"},{"issue":"1441","key":"1730_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1098\/rstb.2003.1371","volume":"359","author":"S Ganesan","year":"2004","unstructured":"Ganesan S, et al. Association of BRCA1 with the inactive X chromosome and XIST RNA. Philos Trans R Soc Lond B Biol Sci. 2004;359(1441):123\u20138.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"1730_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1):129.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1730_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3748\/wjg.v28.i1.108","volume":"28","author":"G Rompianesi","year":"2022","unstructured":"Rompianesi G, et al. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World J Gastroenterol. 2022;28(1):108\u201322.","journal-title":"World J Gastroenterol"},{"key":"1730_CR23","doi-asserted-by":"crossref","first-page":"1509195","DOI":"10.3389\/fimmu.2024.1509195","volume":"15","author":"T Yan","year":"2024","unstructured":"Yan T, Shi J. Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy. Front Immunol. 2024;15:1509195.","journal-title":"Front Immunol"},{"issue":"1","key":"1730_CR24","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1038\/s41598-017-16500-4","volume":"7","author":"OG Shaker","year":"2017","unstructured":"Shaker OG, Senousy MA, Elbaz EM. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients. Sci Rep. 2017;7(1):16246.","journal-title":"Sci Rep"},{"key":"1730_CR25","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0090-8258(21)00809-X","volume":"162","author":"D Ikoma","year":"2021","unstructured":"Ikoma D, et al. An SNP at the 8q24 region (rs6983267) is associated with better survival and chemo-response in high-grade serous ovarian cancer. Gynecol Oncol. 2021;162:S89.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1730_CR26","doi-asserted-by":"crossref","first-page":"19329","DOI":"10.4238\/2015.December.29.43","volume":"14","author":"HS Zhu","year":"2015","unstructured":"Zhu HS, et al. Association between the 8q24 rs6983267 T\/G polymorphism and prostate cancer risk: a meta-analysis. Genet Mol Res. 2015;14(4):19329\u201341.","journal-title":"Genet Mol Res"},{"issue":"18","key":"1730_CR27","doi-asserted-by":"crossref","first-page":"25528","DOI":"10.18632\/oncotarget.8186","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, et al. Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer. Oncotarget. 2016;7(18):25528\u201334.","journal-title":"Oncotarget"},{"issue":"42","key":"1730_CR28","doi-asserted-by":"crossref","first-page":"68002","DOI":"10.18632\/oncotarget.12009","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects. Oncotarget. 2016;7(42):68002.","journal-title":"Oncotarget"},{"issue":"8","key":"1730_CR29","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ng2098","volume":"39","author":"CA Haiman","year":"2007","unstructured":"Haiman CA, et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet. 2007;39(8):954\u20136.","journal-title":"Nat Genet"},{"issue":"13","key":"1730_CR30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djn190","volume":"100","author":"M Ghoussaini","year":"2008","unstructured":"Ghoussaini M, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst. 2008;100(13):962\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1730_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037943","volume":"7","author":"F Bertucci","year":"2012","unstructured":"Bertucci F, et al. 8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer. PLoS ONE. 2012;7(5): e37943.","journal-title":"PLoS ONE"},{"issue":"7","key":"1730_CR32","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.0906067107","volume":"107","author":"J Sotelo","year":"2010","unstructured":"Sotelo J, et al. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci U S A. 2010;107(7):3001\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1730_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ccr.2007.07.027","volume":"12","author":"GA Calin","year":"2007","unstructured":"Calin GA, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12(3):215\u201329.","journal-title":"Cancer Cell"},{"issue":"9","key":"1730_CR34","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1101\/gr.152942.112","volume":"23","author":"H Ling","year":"2013","unstructured":"Ling H, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446\u201361.","journal-title":"Genome Res"},{"issue":"5307","key":"1730_CR35","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek V, et al. Constitutive transcriptional activation by a \u03b2-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma. Science. 1997;275(5307):1784\u20137.","journal-title":"Science"},{"issue":"1","key":"1730_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"5","key":"1730_CR37","first-page":"300060521101993","volume":"49","author":"C Yang","year":"2021","unstructured":"Yang C, et al. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the \u03b2-catenin\/WISP1 signaling pathway. J Int Med Res. 2021;49(5):3000605211019938.","journal-title":"J Int Med Res"},{"issue":"1","key":"1730_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12967-019-1769-7","volume":"17","author":"Y Liu","year":"2019","unstructured":"Liu Y, et al. The emerging role of WISP proteins in tumorigenesis and cancer therapy. J Transl Med. 2019;17(1):28.","journal-title":"J Transl Med"},{"issue":"6","key":"1730_CR39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1078-0432.CCR-10-1178","volume":"17","author":"F Galimberti","year":"2011","unstructured":"Galimberti F, et al. Anaphase catastrophe is a target for cancer therapy. Clin Cancer Res. 2011;17(6):1218\u201322.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1730_CR40","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","volume":"159","author":"B Chen","year":"2020","unstructured":"Chen B, et al. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 2020;159(6):2146-2162.e33.","journal-title":"Gastroenterology"},{"issue":"1","key":"1730_CR41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.24372","volume":"54","author":"KY Chung","year":"2011","unstructured":"Chung KY, et al. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology. 2011;54(1):307\u201318.","journal-title":"Hepatology"},{"issue":"4","key":"1730_CR42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","volume":"61","author":"RS Redis","year":"2016","unstructured":"Redis RS, et al. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell. 2016;61(4):520\u201334.","journal-title":"Mol Cell"},{"issue":"5","key":"1730_CR43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272\u201383.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"1730_CR44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3727\/096504017X14953948675412","volume":"26","author":"F Hua","year":"2018","unstructured":"Hua F, et al. Long noncoding RNA CCAT2 knockdown suppresses tumorous progression by sponging miR-424 in epithelial ovarian cancer. Oncol Res. 2018;26(2):241\u20137.","journal-title":"Oncol Res"},{"issue":"1\u20132","key":"1730_CR45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-020-03712-y","volume":"468","author":"SL Sun","year":"2020","unstructured":"Sun SL, Shu YG, Tao MY. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424. Mol Cell Biochem. 2020;468(1\u20132):69\u201382.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"1730_CR46","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/onc.2012.121","volume":"32","author":"J Xu","year":"2013","unstructured":"Xu J, et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. 2013;32(8):976\u201387.","journal-title":"Oncogene"},{"key":"1730_CR47","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2147\/OTT.S227831","volume":"66","author":"J Ding","year":"2020","unstructured":"Ding J, et al. lncRNA CCAT2 enhanced resistance of glioma cells against chemodrugs by disturbing the normal function of miR-424. OncoTargets Ther. 2020;66:1431\u201345.","journal-title":"OncoTargets Ther"},{"issue":"18","key":"1730_CR48","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1111\/jcmm.16859","volume":"25","author":"J Shi","year":"2021","unstructured":"Shi J, Guo C, Ma J. CCAT2 enhances autophagy-related invasion and metastasis via regulating miR-4496 and ELAVL1 in hepatocellular carcinoma. J Cell Mol Med. 2021;25(18):8985\u201396.","journal-title":"J Cell Mol Med"},{"issue":"23","key":"1730_CR49","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1097\/CM9.0000000000002286","volume":"135","author":"S Ma","year":"2022","unstructured":"Ma S, et al. Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers. Chin Med J (Engl). 2022;135(23):2785\u201397.","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"1730_CR50","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/jcmm.13518","volume":"22","author":"L Yan","year":"2018","unstructured":"Yan L, et al. LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion. J Cell Mol Med. 2018;22(5):2592\u20139.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1730_CR51","first-page":"2978","volume":"22","author":"R Ruan","year":"2018","unstructured":"Ruan R, Zhao XL. LncRNA CCAT2 enhances cell proliferation via GSK3\u03b2\/\u03b2-catenin signaling pathway in human osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(10):2978\u201384.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1730_CR52","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s11010-020-04042-9","volume":"476","author":"M Chen","year":"2021","unstructured":"Chen M, et al. Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth. Mol Cell Biochem. 2021;476(4):1871\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"1730_CR53","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3892\/or.2017.5742","volume":"38","author":"HL Lang","year":"2017","unstructured":"Lang HL, et al. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. Oncol Rep. 2017;38(2):785\u201398.","journal-title":"Oncol Rep"},{"issue":"49","key":"1730_CR54","doi-asserted-by":"crossref","first-page":"81806","DOI":"10.18632\/oncotarget.13242","volume":"7","author":"H Guo","year":"2016","unstructured":"Guo H, et al. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells. Oncotarget. 2016;7(49):81806\u201314.","journal-title":"Oncotarget"},{"issue":"6","key":"1730_CR55","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3727\/096504016X14792098307036","volume":"25","author":"J Zeng","year":"2017","unstructured":"Zeng J, et al. Knockdown of long noncoding RNA CCAT2 inhibits cellular proliferation, invasion, and epithelial-mesenchymal transition in glioma cells. Oncol Res. 2017;25(6):913\u201321.","journal-title":"Oncol Res"},{"issue":"10","key":"1730_CR56","first-page":"944","volume":"55","author":"SK Zhou","year":"2020","unstructured":"Zhou SK, et al. Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;55(10):944\u201351.","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"7","key":"1730_CR57","doi-asserted-by":"crossref","first-page":"101042831771131","DOI":"10.1177\/1010428317711314","volume":"39","author":"JL Huang","year":"2017","unstructured":"Huang JL, et al. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt\/\u03b2-catenin signaling pathway in clear cell renal cell carcinoma. Tumour Biol. 2017;39(7):1010428317711314.","journal-title":"Tumour Biol"},{"issue":"3","key":"1730_CR58","first-page":"436","volume":"65","author":"G Wu","year":"2023","unstructured":"Wu G, et al. LncRNA CCAT2 promotes the proliferation and invasion of renal cell cancer by sponging miR-320a. Panminerva Med. 2023;65(3):436\u20137.","journal-title":"Panminerva Med"},{"issue":"23","key":"1730_CR59","first-page":"12224","volume":"24","author":"W Fu","year":"2020","unstructured":"Fu W, et al. CCAT2 contributes to progression and treatment resistance of thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(23):12224\u201331.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"1730_CR60","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3892\/ijmm.2020.4761","volume":"46","author":"S Xin","year":"2020","unstructured":"Xin S, Ye X. Knockdown of long non-coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt\/\u03b2-catenin pathway. Int J Mol Med. 2020;46(6):2047\u201356.","journal-title":"Int J Mol Med"},{"issue":"1","key":"1730_CR61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, et al. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):49.","journal-title":"Diagn Pathol"},{"issue":"12","key":"1730_CR62","first-page":"11771","volume":"10","author":"BD Wang","year":"2017","unstructured":"Wang BD, et al. Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway. Int J Clin Exp Pathol. 2017;10(12):11771\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"1730_CR63","first-page":"3369","volume":"15","author":"B Wang","year":"2018","unstructured":"Wang B, et al. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 2018;15(3):3369\u201375.","journal-title":"Oncol Lett"},{"key":"1730_CR64","volume":"152","author":"Z Xu","year":"2020","unstructured":"Xu Z, et al. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells. Pharmacol Res. 2020;152: 104628.","journal-title":"Pharmacol Res"},{"key":"1730_CR65","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.biopha.2017.05.030","volume":"91","author":"X Deng","year":"2017","unstructured":"Deng X, et al. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer. Biomed Pharmacother. 2017;91:1160\u20136.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1730_CR66","first-page":"706","volume":"21","author":"ZJ Wu","year":"2017","unstructured":"Wu ZJ, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-\u03b2 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4):706\u201314.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1730_CR67","first-page":"821","volume":"50","author":"Y Cai","year":"2016","unstructured":"Cai Y, He J, Zhang D. Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells\u2019 response to tamoxifen. Mol Biol (Mosk). 2016;50(5):821\u20137.","journal-title":"Mol Biol (Mosk)"},{"key":"1730_CR68","first-page":"2657","volume":"8","author":"Y Cai","year":"2015","unstructured":"Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657\u201364.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"1730_CR69","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2016.08.120","volume":"480","author":"J Zheng","year":"2016","unstructured":"Zheng J, et al. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2016;480(4):508\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1730_CR70","first-page":"97","volume":"20","author":"P He","year":"2020","unstructured":"He P, et al. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2020;20(4):97.","journal-title":"Oncol Lett"},{"issue":"20","key":"1730_CR71","doi-asserted-by":"crossref","first-page":"28989","DOI":"10.18632\/oncotarget.8259","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, et al. shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells. Oncotarget. 2016;7(20):28989\u201397.","journal-title":"Oncotarget"},{"issue":"2","key":"1730_CR72","first-page":"245","volume":"8","author":"D Fu","year":"2018","unstructured":"Fu D, Zhang Y, Cui H. Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas. Am J Cancer Res. 2018;8(2):245\u201355.","journal-title":"Am J Cancer Res"},{"key":"1730_CR73","doi-asserted-by":"crossref","first-page":"875","DOI":"10.12659\/MSM.897754","volume":"22","author":"L Wu","year":"2016","unstructured":"Wu L, et al. Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis. Med Sci Monit. 2016;22:875\u20139.","journal-title":"Med Sci Monit"},{"issue":"12","key":"1730_CR74","first-page":"5658","volume":"11","author":"JJ Li","year":"2018","unstructured":"Li JJ, et al. Upregulation of lncRNA CCAT2 predicts poor prognosis in patients with acute myeloid leukemia and is correlated with leukemic cell proliferation. Int J Clin Exp Pathol. 2018;11(12):5658\u201366.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"1730_CR75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","volume":"23","author":"M Araghi","year":"2023","unstructured":"Araghi M, et al. Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell Int. 2023;23(1):162.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1730_CR76","first-page":"312","volume":"51","author":"L He","year":"2020","unstructured":"He L, et al. Effects of shRNA on cisplatin-resistant non-small cell lung cancer cell A549 via silencing CCAT2. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51(3):312\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"6","key":"1730_CR77","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1007\/s13277-014-1700-z","volume":"35","author":"M Qiu","year":"2014","unstructured":"Qiu M, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014;35(6):5375\u201380.","journal-title":"Tumour Biol"},{"key":"1730_CR78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biopha.2016.05.017","volume":"82","author":"S Chen","year":"2016","unstructured":"Chen S, et al. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Biomed Pharmacother. 2016;82:583\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1730_CR79","first-page":"4600","volume":"16","author":"C Zhao","year":"2018","unstructured":"Zhao C, et al. Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2018;16(4):4600\u20136.","journal-title":"Oncol Lett"},{"key":"1730_CR80","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopha.2016.12.122","volume":"87","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, et al. LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer. Biomed Pharmacother. 2017;87:692\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1730_CR81","first-page":"1840","volume":"25","author":"P Gao","year":"2020","unstructured":"Gao P, et al. LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells. J buon. 2020;25(4):1840\u20136.","journal-title":"J buon"},{"issue":"1","key":"1730_CR82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-017-0725-5","volume":"16","author":"Y Yu","year":"2017","unstructured":"Yu Y, et al. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells. Mol Cancer. 2017;16(1):155.","journal-title":"Mol Cancer"},{"issue":"10","key":"1730_CR83","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/0115680096274757231219072003","volume":"24","author":"Y Xing","year":"2024","unstructured":"Xing Y, et al. Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer. Curr Cancer Drug Targets. 2024;24(10):1071\u20139.","journal-title":"Curr Cancer Drug Targets"},{"key":"1730_CR84","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Li Z, Yin H. Long non-coding RNA CCAT2 activates RAB14 and acts as an oncogene in colorectal cancer. Front Oncol. 2021;11: 751903.","journal-title":"Front Oncol"},{"issue":"6","key":"1730_CR85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286486","volume":"18","author":"C Franz","year":"2023","unstructured":"Franz C, et al. Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes. PLoS ONE. 2023;18(6): e0286486.","journal-title":"PLoS ONE"},{"issue":"4","key":"1730_CR86","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2016.02.006","volume":"61","author":"RS Redis","year":"2016","unstructured":"Redis RS, et al. Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2. Mol Cell. 2016;61(4):640.","journal-title":"Mol Cell"},{"issue":"8","key":"1730_CR87","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdx248","volume":"28","author":"T Ozawa","year":"2017","unstructured":"Ozawa T, et al. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 \u2018gene desert\u2019, serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 2017;28(8):1882\u20138.","journal-title":"Ann Oncol"},{"issue":"1","key":"1730_CR88","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41598-020-79906-7","volume":"11","author":"LF Thean","year":"2021","unstructured":"Thean LF, et al. Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis. Sci Rep. 2021;11(1):404.","journal-title":"Sci Rep"},{"issue":"1","key":"1730_CR89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000452143","volume":"92","author":"Y Kasagi","year":"2017","unstructured":"Kasagi Y, et al. The expression of CCAT2, a novel long noncoding RNA transcript, and rs6983267 single-nucleotide polymorphism genotypes in colorectal cancers. Oncology. 2017;92(1):48\u201354.","journal-title":"Oncology"},{"key":"1730_CR90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.omtn.2018.05.009","volume":"12","author":"C Barbagallo","year":"2018","unstructured":"Barbagallo C, et al. LncRNA UCA1, upregulated in CRC biopsies and downregulated in serum exosomes, controls mRNA expression by RNA-RNA interactions. Mol Ther Nucleic Acids. 2018;12:229\u201341.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"1730_CR91","first-page":"6907","volume":"14","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Oncol Lett. 2017;14(6):6907\u201314.","journal-title":"Oncol Lett"},{"issue":"34","key":"1730_CR92","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.3748\/wjg.v25.i34.5026","volume":"25","author":"O Galamb","year":"2019","unstructured":"Galamb O, et al. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors. World J Gastroenterol. 2019;25(34):5026\u201348.","journal-title":"World J Gastroenterol"},{"key":"1730_CR93","volume":"113","author":"L Wang","year":"2019","unstructured":"Wang L, et al. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer. Biomed Pharmacother. 2019;113: 108758.","journal-title":"Biomed Pharmacother"},{"issue":"10251","key":"1730_CR94","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"1","key":"1730_CR95","first-page":"779","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang CY, et al. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015;8(1):779\u201385.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"1730_CR96","first-page":"317","volume":"108","author":"SW Wu","year":"2017","unstructured":"Wu SW, et al. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion. Minerva Med. 2017;108(4):317\u201323.","journal-title":"Minerva Med"},{"issue":"1","key":"1730_CR97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7150\/thno.16044","volume":"7","author":"K Zhang","year":"2017","unstructured":"Zhang K, et al. Genome-wide lncRNA microarray profiling identifies novel circulating lncRNAs for detection of gastric cancer. Theranostics. 2017;7(1):213\u201327.","journal-title":"Theranostics"},{"issue":"11","key":"1730_CR98","first-page":"2651","volume":"6","author":"YJ Wang","year":"2016","unstructured":"Wang YJ, et al. Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2. Am J Cancer Res. 2016;6(11):2651\u201360.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"1730_CR99","first-page":"3127","volume":"15","author":"ZY Yu","year":"2018","unstructured":"Yu ZY, et al. Effect of silencing colon cancer-associated transcript 2 on the proliferation, apoptosis and autophagy of gastric cancer BGC-823 cells. Oncol Lett. 2018;15(3):3127\u201332.","journal-title":"Oncol Lett"},{"issue":"6","key":"1730_CR100","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s13402-023-00835-4","volume":"46","author":"H Deng","year":"2023","unstructured":"Deng H, et al. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cell Oncol (Dordr). 2023;46(6):1675\u201390.","journal-title":"Cell Oncol (Dordr)"},{"key":"1730_CR101","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.2147\/OTT.S169823","volume":"11","author":"S Gao","year":"2018","unstructured":"Gao S, et al. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Onco Targets Ther. 2018;11:4877\u201391.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"1730_CR102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4274\/tjps.galenos.2021.03502","volume":"19","author":"N Jabbari","year":"2022","unstructured":"Jabbari N, et al. Gemini curcumin suppresses gastric cancer AGS cell proliferation through modulation of lncRNA CCAT2 and c-Myc genes. Turk J Pharm Sci. 2022;19(3):239\u201345.","journal-title":"Turk J Pharm Sci"},{"key":"1730_CR103","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"5","author":"J Balogh","year":"2016","unstructured":"Balogh J, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;5:41\u201353.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"1730_CR104","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ol.2016.4580","volume":"12","author":"N Zhou","year":"2016","unstructured":"Zhou N, et al. Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis. Oncol Lett. 2016;12(1):132\u20138.","journal-title":"Oncol Lett"},{"issue":"4","key":"1730_CR105","first-page":"5328","volume":"17","author":"JG Bai","year":"2018","unstructured":"Bai JG, et al. Upregulation of long non-coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma. Mol Med Rep. 2018;17(4):5328\u201335.","journal-title":"Mol Med Rep"},{"issue":"42","key":"1730_CR106","volume":"98","author":"C Fu","year":"2019","unstructured":"Fu C, et al. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma. Medicine (Baltimore). 2019;98(42): e17412.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"1730_CR107","first-page":"1423","volume":"7","author":"F Chen","year":"2017","unstructured":"Chen F, et al. A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth. Am J Cancer Res. 2017;7(7):1423\u201334.","journal-title":"Am J Cancer Res"},{"key":"1730_CR108","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2147\/OTT.S127100","volume":"10","author":"Y Xu","year":"2017","unstructured":"Xu Y, et al. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition. Onco Targets Ther. 2017;10:1191\u20138.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1730_CR109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yexcr.2019.03.029","volume":"379","author":"Y Liu","year":"2019","unstructured":"Liu Y, et al. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. Exp Cell Res. 2019;379(1):19\u201329.","journal-title":"Exp Cell Res"},{"issue":"9","key":"1730_CR110","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1002\/jcp.29630","volume":"235","author":"C Niu","year":"2020","unstructured":"Niu C, et al. CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression. J Cell Physiol. 2020;235(9):6307\u201320.","journal-title":"J Cell Physiol"},{"issue":"23","key":"1730_CR111","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3748\/wjg.v24.i23.2482","volume":"24","author":"BG Wang","year":"2018","unstructured":"Wang BG, et al. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: a case-control study. World J Gastroenterol. 2018;24(23):2482\u201390.","journal-title":"World J Gastroenterol"},{"issue":"16","key":"1730_CR112","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/ijerph16162833","volume":"16","author":"ER Wu","year":"2019","unstructured":"Wu ER, et al. Association of lncRNA CCAT2 and CASC8 gene polymorphisms with hepatocellular carcinoma. Int J Environ Res Public Health. 2019;16(16):2833.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"1730_CR113","doi-asserted-by":"crossref","first-page":"e12342","DOI":"10.1111\/cpr.12342","volume":"50","author":"Y Xin","year":"2017","unstructured":"Xin Y, et al. CCAT2: a novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017;50(3):e12342.","journal-title":"Cell Prolif"},{"issue":"2","key":"1730_CR114","first-page":"1745","volume":"18","author":"X Wang","year":"2019","unstructured":"Wang X, Wang X. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway. Oncol Lett. 2019;18(2):1745\u201354.","journal-title":"Oncol Lett"},{"key":"1730_CR115","doi-asserted-by":"crossref","first-page":"1224269","DOI":"10.3389\/fimmu.2023.1224269","volume":"14","author":"J Xing","year":"2023","unstructured":"Xing J, et al. Factors impacting the benefits and pathogenicity of Th17 cells in the tumor microenvironment. Front Immunol. 2023;14:1224269.","journal-title":"Front Immunol"},{"issue":"7","key":"1730_CR116","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1007\/s13277-015-3220-x","volume":"36","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Tumour Biol. 2015;36(7):5523\u20138.","journal-title":"Tumour Biol"},{"key":"1730_CR117","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, et al. Long non-coding RNA CCAT2 promotes the development of esophageal squamous cell carcinoma by inhibiting miR-200b to upregulate the IGF2BP2\/TK1 axis. Front Oncol. 2021;11: 680642.","journal-title":"Front Oncol"},{"issue":"1","key":"1730_CR118","first-page":"327","volume":"56","author":"M Wang","year":"2020","unstructured":"Wang M, et al. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145\/p70S6K1 and p53 pathway. Int J Oncol. 2020;56(1):327\u201336.","journal-title":"Int J Oncol"},{"issue":"7","key":"1730_CR119","doi-asserted-by":"crossref","first-page":"101042831771767","DOI":"10.1177\/1010428317717670","volume":"39","author":"Y Ma","year":"2017","unstructured":"Ma Y, et al. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt\/\u03b2-catenin pathway. Tumour Biol. 2017;39(7):1010428317717670.","journal-title":"Tumour Biol"},{"issue":"6","key":"1730_CR120","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s13577-021-00606-z","volume":"34","author":"Y Zang","year":"2021","unstructured":"Zang Y, et al. Long non-coding RNA CCAT2 drives the growth of laryngeal squamous cell carcinoma via regulating YAP activity. Hum Cell. 2021;34(6):1878\u201387.","journal-title":"Hum Cell"},{"issue":"7","key":"1730_CR121","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jso.23888","volume":"111","author":"X Zhang","year":"2015","unstructured":"Zhang X, et al. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol. 2015;111(7):834\u20139.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1730_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-017-0149-0","volume":"51","author":"Y Cai","year":"2018","unstructured":"Cai Y, et al. CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. Biol Res. 2018;51(1):1.","journal-title":"Biol Res"},{"issue":"1","key":"1730_CR123","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13287-022-03180-9","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, et al. Targeting cancer stem cells with polymer nanoparticles for gastrointestinal cancer treatment. Stem Cell Res Ther. 2022;13(1):489.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"1730_CR124","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/14728222.2014.941285","volume":"18","author":"J Zhao","year":"2014","unstructured":"Zhao J, et al. Long noncoding RNAs in liver cancer: what we know in 2014. Expert Opin Ther Targets. 2014;18(10):1207\u201318.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"1730_CR125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jcp.30566","volume":"237","author":"B Hui","year":"2022","unstructured":"Hui B, et al. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer. J Cell Physiol. 2022;237(1):911\u201333.","journal-title":"J Cell Physiol"},{"key":"1730_CR126","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.12659\/MSM.900688","volume":"22","author":"Q Fang","year":"2016","unstructured":"Fang Q, Chen X, Zhi X. Long non-coding RNA (LncRNA) urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b. Med Sci Monit. 2016;22:3506\u201313.","journal-title":"Med Sci Monit"},{"issue":"5","key":"1730_CR127","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00280-016-3029-3","volume":"77","author":"C Shang","year":"2016","unstructured":"Shang C, et al. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Cancer Chemother Pharmacol. 2016;77(5):1061\u20137.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1730_CR128","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114407","volume":"163","author":"SA Hosseini","year":"2023","unstructured":"Hosseini SA, et al. Long non-coding RNAs and gastric cancer: an update of potential biomarkers and therapeutic applications. Biomed Pharmacother. 2023;163: 114407.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1730_CR129","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/aps.2016.164","volume":"38","author":"WJ Gong","year":"2017","unstructured":"Gong WJ, et al. Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer. Acta Pharmacol Sin. 2017;38(4):581\u201390.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"1730_CR130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jcmm.17041","volume":"26","author":"D Zhou","year":"2022","unstructured":"Zhou D, et al. Long noncoding RNA CCAT2 reduces chemosensitivity to 5-fluorouracil in breast cancer cells by activating the mTOR axis. J Cell Mol Med. 2022;26(5):1392\u2013401.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01730-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01730-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01730-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:49:51Z","timestamp":1764917391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01730-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01730-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not used artificial intelligence in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI utilization"}}],"article-number":"197"}}